gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with indocyanine green in 2 studies
Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (indocyanine green) | Trials (indocyanine green) | Recent Studies (post-2010) (indocyanine green) |
---|---|---|---|---|---|
638 | 31 | 243 | 9,939 | 589 | 5,488 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JC; Chien, YH; Ho, HY; Ho, WY; Huang, CC; Hung, ST; Liau, MC; Su, CH; Yeh, CS | 1 |
Deng, K; Huang, SW; Li, XQ; Li, YS; Liao, RF; Lu, ST; Wan, B; Wu, B; Wu, BL; Xu, HB | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and indocyanine green
Article | Year |
---|---|
Tumor targeting and MR imaging with lipophilic cyanine-mediated near-infrared responsive porous Gd silicate nanoparticles.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Endocytosis; Fibroblasts; Fluorescence; Gadolinium; Heterocyclic Compounds; Humans; Indocyanine Green; Lipids; Magnetic Resonance Imaging; Mice; Mice, SCID; Nanoparticles; Neoplasms; Organ Specificity; Organometallic Compounds; Porosity; Propylamines; Silanes; Silicates; Spectroscopy, Near-Infrared; Time Factors | 2013 |
Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy.
Topics: Animals; Contrast Media; Female; Heterocyclic Compounds; Humans; Indocyanine Green; Infrared Rays; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Phototherapy; Signal-To-Noise Ratio; Theranostic Nanomedicine | 2017 |